HK1061858A1 - Benzoxazepine derivatives and their use as apma receptor stimulators - Google Patents

Benzoxazepine derivatives and their use as apma receptor stimulators

Info

Publication number
HK1061858A1
HK1061858A1 HK04104926A HK04104926A HK1061858A1 HK 1061858 A1 HK1061858 A1 HK 1061858A1 HK 04104926 A HK04104926 A HK 04104926A HK 04104926 A HK04104926 A HK 04104926A HK 1061858 A1 HK1061858 A1 HK 1061858A1
Authority
HK
Hong Kong
Prior art keywords
apma
benzoxazepine derivatives
receptor stimulators
stimulators
receptor
Prior art date
Application number
HK04104926A
Other languages
English (en)
Inventor
Grove Simon James Anthony
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of HK1061858A1 publication Critical patent/HK1061858A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK04104926A 2001-06-11 2004-07-07 Benzoxazepine derivatives and their use as apma receptor stimulators HK1061858A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01202215 2001-06-11
PCT/EP2002/006185 WO2002100865A1 (en) 2001-06-11 2002-06-05 Benzoxazepine derivatives and their use as ampa receptor stimulators

Publications (1)

Publication Number Publication Date
HK1061858A1 true HK1061858A1 (en) 2004-10-08

Family

ID=8180450

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104926A HK1061858A1 (en) 2001-06-11 2004-07-07 Benzoxazepine derivatives and their use as apma receptor stimulators

Country Status (30)

Country Link
US (2) US7307073B2 (is)
EP (1) EP1399450B1 (is)
JP (1) JP4435561B2 (is)
KR (1) KR100863255B1 (is)
CN (1) CN1257908C (is)
AR (1) AR036092A1 (is)
AT (1) ATE389659T1 (is)
AU (1) AU2002314144B2 (is)
BR (1) BR0210222A (is)
CA (1) CA2450274C (is)
CO (1) CO5550447A2 (is)
CZ (1) CZ300052B6 (is)
DE (1) DE60225689T2 (is)
EC (1) ECSP034891A (is)
ES (1) ES2301651T3 (is)
HK (1) HK1061858A1 (is)
HR (1) HRP20031007A2 (is)
HU (1) HUP0400154A3 (is)
IL (2) IL158905A0 (is)
IS (1) IS2526B (is)
MX (1) MXPA03011563A (is)
NO (1) NO328705B1 (is)
NZ (1) NZ529670A (is)
PE (1) PE20030097A1 (is)
PL (1) PL366721A1 (is)
RU (1) RU2279434C2 (is)
SK (1) SK287150B6 (is)
TW (1) TWI232863B (is)
WO (1) WO2002100865A1 (is)
ZA (1) ZA200309382B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100864267B1 (ko) 2001-06-14 2008-10-20 엔.브이.오가논 ＡＭＰＡ 수용체의 양성 조절제로서의(피리도/티에노)-[ｆ]-옥사제핀-5-온 유도체
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
ES2444779T3 (es) * 2009-09-28 2014-02-26 F. Hoffmann-La Roche Ag Compuestos de benzoxazepina inhibidores de la PI3K y su utilización en el tratamiento de cáncer
FR2964969B1 (fr) 2010-09-16 2012-08-24 Servier Lab Nouveaux derives dihydrobenzoxathiazepines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2915405A1 (en) 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
AU2017353986B2 (en) 2016-11-07 2021-08-19 Arbutus Biopharma Corporation Substituted pyridinone-containing tricyclic compounds, and methods using same
TWI801517B (zh) 2018-03-12 2023-05-11 加拿大商愛彼特生物製藥公司 經取代的2-吡啶酮三環化合物、其類似物及其使用方法
TW202010499A (zh) 2018-04-12 2020-03-16 加拿大商愛彼特生物製藥公司 經取代的吡啶酮之三環化合物的製備方法
EP4121072A1 (en) * 2020-03-20 2023-01-25 Amathus Therapeutics, Inc. Cyclic sulfonamide derivatives as trap1 modulators and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238719A (is) 1968-11-01 1971-07-07
ATE215079T1 (de) 1992-07-24 2002-04-15 Univ California Arzneimittel, die den durch ampa rezeptoren vermittelten synaptischen respons erhöhen
US6174881B1 (en) 1995-01-06 2001-01-16 Hoffman-La Roche Inc. Hydroxymethylimidazodiazepines and their esters
US5650409A (en) * 1995-06-02 1997-07-22 Cortex Pharmaceuticals, Inc. Benzoyl piperidines/pyrrolidines for enhancing synaptic response
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
DE69831446T2 (de) 1997-06-09 2006-06-14 Pfizer Prod Inc Chinazolin-4-on AMPA Antagonisten
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
EP1071426A2 (en) * 1998-02-18 2001-01-31 Neurosearch A/S Novel compounds and their use as positive ampa receptor modulators
US6124278A (en) 1998-04-03 2000-09-26 The Regents Of The University Of California Acylbenzoxazines for enhancing synaptic response

Also Published As

Publication number Publication date
KR20040006030A (ko) 2004-01-16
NO328705B1 (no) 2010-05-03
EP1399450A1 (en) 2004-03-24
CN1514835A (zh) 2004-07-21
SK287150B6 (sk) 2010-01-07
WO2002100865A1 (en) 2002-12-19
AR036092A1 (es) 2004-08-11
CN1257908C (zh) 2006-05-31
MXPA03011563A (es) 2004-03-18
NZ529670A (en) 2006-02-24
CZ20033376A3 (en) 2004-04-14
DE60225689T2 (de) 2008-07-17
TWI232863B (en) 2005-05-21
ATE389659T1 (de) 2008-04-15
PE20030097A1 (es) 2003-02-08
KR100863255B1 (ko) 2008-10-15
HUP0400154A3 (en) 2007-05-02
IL158905A (en) 2008-12-29
RU2004100310A (ru) 2005-06-10
EP1399450B1 (en) 2008-03-19
HUP0400154A2 (hu) 2004-07-28
IS2526B (is) 2009-07-15
NO20035486D0 (no) 2003-12-10
US20080139529A1 (en) 2008-06-12
JP2004533466A (ja) 2004-11-04
AU2002314144B2 (en) 2008-01-31
IS7036A (is) 2003-11-13
US7504390B2 (en) 2009-03-17
ZA200309382B (en) 2005-03-02
IL158905A0 (en) 2004-05-12
PL366721A1 (en) 2005-02-07
US20040171605A1 (en) 2004-09-02
CZ300052B6 (cs) 2009-01-21
DE60225689D1 (de) 2008-04-30
ES2301651T3 (es) 2008-07-01
JP4435561B2 (ja) 2010-03-17
BR0210222A (pt) 2004-04-13
CO5550447A2 (es) 2005-08-31
RU2279434C2 (ru) 2006-07-10
CA2450274C (en) 2010-12-21
US7307073B2 (en) 2007-12-11
HRP20031007A2 (en) 2005-10-31
CA2450274A1 (en) 2002-12-19
ECSP034891A (es) 2004-01-28
SK15182003A3 (sk) 2004-05-04

Similar Documents

Publication Publication Date Title
IL161384A0 (en) Bicyclic oxopyridine and oxopyrimidine derivatives
TWI371450B (en) Novel substituted dihydro 3-halo-1h-pyrazole-5-carboxylates,their preparation and use
IL166100A0 (en) 7,8,9-10-tetrahydro-6h-azepino,6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2h-pyrroloÄ2,1-bÜ quinazolinone derivatives
IL159275A0 (en) Phenylsulfonyl-1, 3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use
PL377239A1 (pl) Nowe amino-podstawione pochodne dihydropirymido [4,5-d]-pirymidynonu, ich wytwarzanie i zastosowanie jako środków framaceutycznych
AU2003284808A8 (en) The derivatives of pyridone and the use of them
AU2002359126A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
PL375699A1 (en) Pyrazolopyridines and methods of making and using the same
AU2002359123A8 (en) Benzodiazepine derivatives, preparation thereof and use thereof
TWI318974B (en) Acylaminothiazole derivatives, their preparation and their therapeutic use
HK1061858A1 (en) Benzoxazepine derivatives and their use as apma receptor stimulators
PL375709A1 (en) Derivatives of [6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonylamino]-propionamide
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
GB0126889D0 (en) Compounds and their uses
HUP0401162A3 (en) Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
PL365342A1 (en) Mikanolide derivatives, their preparation and therapeutic uses
IL160093A0 (en) Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists
HK1065792A1 (en) 3-Heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino Ä4,5-BÜindole-1-carboxamide derivatives, their preparation and therapeutic use
EP1420006A4 (en) ALKYLENEBINAPHTOL DERIVATIVES AND LOAD REGULATION AGENT COMPRISING SAID DERIVATIVES
GB0027548D0 (en) Bicyclic amide derivatives
GB0107282D0 (en) Acromial prosthesis
GB0124346D0 (en) Receptor and its use
IL156593A0 (en) Mikanolide derivatives, their preparation and therapeutic uses

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20120605